In situ hybridization was used to characterize the expression pattern of the T : G mismatch-speci®c thymidine-DNA glycosylase (TDG) gene, encoding a DNA repair enzyme which corrects G : T mismatches that result from the hydrolytic deamination of 5-methyl cytosines. TDG transcripts were uniformly and ubiquitously expressed from 7.5 ± 13.5 days post-coitum, but were then markedly enriched in speci®c tissues of the developing fetus. At 14.5 gestational days, TDG was strongly expressed in the developing nervous system, thymus, lung, liver, kidney and intestine. At later stages, high levels of expression were detected in the thymus, brain, nasal epithelium and within proliferating regions of the intestine, skin, kidney, teeth and bone. This pattern of expression strongly correlated with those of the methyl transferase (MTase) gene, coding for the enzyme which speci®cally methylates CpG dinucleotides, and the p53 tumour suppressor gene. However, TDG and MTase were dierentially expressed during maturation of the male and female germline. We also report that tumors occuring in mice which overexpress MMTV-vHa-ras or MMTV-c-myc transgenes or mice heterozygous for p53 gene disruption, all show elevated TDG and MTase expression speci®c to the transformed tissue.
Introduction
Methylation of DNA plays an important role in growth control and dierentiation. This epigenetic modi®cation has a general role in the control of gene expression in a cell type-speci®c manner (Eden and Cedar, 1994) , along with eecting two important processes: genomic imprinting (Razin and and X chromosome inactivation in females (Panning and Jaenisch, 1996) . De novo methylation occurs during embryogenesis and involves the addition of a methyl group to the ®fth carbon of the pyrimidine ring of cytosines within speci®c loci enriched in CpG dinucleotides (Bird, 1986) . Methylation of CpG sites is carried out by DNA methyl transferase (MTase), the only enzyme identi®ed that can achieve both de novo methylation of DNA during development and maintenance methylation during subsequent replication steps (Bestor and Verdine, 1994; Ahmad and Rao, 1996) . MTase is required in all dividing cells to maintain gene expression patterns and its activity is essential for embryonic development, as targeted disruption of this gene in the mouse results in severe abnormalities and death of the embryos at the 4 ± 10 somite stage (Li et al., 1992) . However, some residual methylation of cytosines still occurs in these mutants, possibly indicating the existence of an additional de novo DNA methyl transferase(s) or of some other methylation mechanisms.
Methylation of cytosines is also the source of genomic instability due to deamination of 5'-methylcytosines (Me-C) by spontaneous hydrolysis, which produces thymines and results in G : T mismatches (Lindahl, 1993) . Such deaminations of Me-C represent the most frequent cause of endogenous mutagenesis (Jones, 1996; Jones and Gonzalgo, 1997) . In addition, there is evidence that active mechanisms can also contribute to deamination of Me-C (Shen et al., 1992) ; indeed, it was shown in vitro that the bacterial MTase M. EcoRII can actively deaminate Me-C to thymines (Yebra and Bhagwat, 1995) . Since Me-C constitute about 1% of mammalian genomic DNA bases, their presence creates a signi®cant risk for mutagenesis. Indeed, 35% of all germline and somatic point mutations found in human diseases occur at CpG sites (Cooper and Yousso®an, 1988) . For instance, methylated CpG sites within the p53 gene are hot spots for mutagenesis (Pfeifer and Holmquist, 1997) . Since p53 functions as a tumor suppressor gene, its inactivation by point mutations can induce cell transformation and neoplastic processes (Greenblatt et al., 1994) .
T : G mismatches are repaired by mismatch-speci®c thymidine-DNA glycosylase (TDG). This enzyme catalyses the cleavage of mismatched thymines, initiating their replacement by cytosines. These non methylated cytosines at hemimethylated CpG sites can be remethylated by MTase during S phase using the maintenance function of the enzyme. Inhibition of TDG activity using blocking antibodies signi®cantly reduces the overall G : T repair rate in vitro, suggesting that no other major G : T repair system exists (Neddermann et al., 1996) . Thus, defects in the eciency in G : T mismatch repair would be expected to contribute to tumorigenesis.
In this study we compare the expression patterns of the TDG and MTase genes in mouse embryos and fetuses, in germline cells, as well as in dierent transgenic mouse models for tumorigenicity. We report that TDG and MTase show highly overlapping tissue-speci®c patterns of expression during late development, which are comparable to those of p53 transcripts. Moreover, MTase and TDG transcripts are abundantly expressed in mammary tumors from mice expressing MMTV-v-Ha-ras or MMTV-c-myc and in osteosarcomas and lymphomas arising in mice heterozygous for a p53 targeted mutation.
Results
Regionally-enriched expression of thymidine-DNA glycosylase during mouse development
In situ hybridization (ISH), a powerful method to study temporal and spatial expression patterns and, thus, to identify in which regions genes may function during normal development, was used to determine the expression pattern of the TDG gene at various stages of mouse development. TDG was uniformly and ubiquitously expressed in all regions of the mouse embryo from 7.5 ± 13.5 days post-coitum (d.p.c.) (data not shown). Region-speci®c dierences in TDG expression levels became apparent in 14.5 d.p.c. fetuses, as mouse development entered a phase of organogenesis and histogenesis. TDG was strongly expressed in the developing central and peripheral nervous system (including the neural retina and spinal cord), in the nasal and mouth epithelia, as well as in thymus, lung, liver, kidney, adrenal gland and intestine ( Figure 1a and data not shown). Moderate levels of expression were seen in the various developing skeletal muscles ( Figure 1b ) and lower levels in cardiac muscle (Figure 1a ), whereas the developing cartilages apparently lacked TDG transcripts (Figure 1b ). In the developing lungs, TDG was preferentially expressed in the bronchi (and tracheal) epithelium and the budding alveoli (Figure 1a and c). Strong expression was seen in the epithelium of the developing intestine, while the underlying mesenchyme was more weakly labeled ( Figure 1d ). Note also the speci®c labeling of both the epithelium and outer mesenchyme of the developing urinary bladder (Figure 1a ).
Tissue-speci®c coexpression of TDG and DNA methyl transferase during late fetal development (Figure 2b and data not shown). In the eye, strong expression was detected in the neural retina and part of the lens epithelium (Figures 2b and 3a) . Pronounced expression was also detected in the developing cochlea epithelium (Figure 2b) . Expression in the tongue and mouth epithelium became restricted to the basal (proliferative) cell layer ( Figure 3b and data not shown). Strong expression was detected in the inner enamel epithelium of the developing tooth buds, which includes the actively dividing ameloblast (enamel producing) cells (Figures 2b and 3b) . A particularly strong signal was seen at the level of the olfactory epithelium in the nasal cavities (Figure 3c ).
The salivary gland epithelium was also labeled ( Figure  2b ).
Among the developing viscera, the thymus, which contains a population of T-cell precursors at various stages of maturation, displayed the highest overall levels of TDG expression (Figure 2b ). Pronounced expression was found in the kidney cortex which contains newly generated nephrons at early stages of dierentiation ( Figure 2b ). TDG transcripts were preferentially distributed in the most basal cell layer of the intestinal epithelium, with strongest expression in the crypt cells (Figures 2b and 3d) . Expresssion was also detected in the proliferative basal layer of the skin epidermis ( Figure 3e ) and in the various hair follicles, including the vibrissae (Figures 2b and 3a, b,e). Moderate levels of expression were still observed in the various developing skeletal muscles, as well as in brown fat cells of the neck region ( Figure 2b and data not shown). Restricted expression was detected in developing bones undergoing endochondral ossification: the signal was speci®c to the bone tissue underlying hypertrophic chondrocytes (zone of elongation of the developing bone) and to the region of transition between perichondrium and periosteum ( Figure 3f ).
Expression of TDG was compared to that of the MTase gene by in situ analysis of serial sections. MTase transcript distribution remained diuse until *14.5 d.p.c. (data not shown), but was clearly similar to that of TDG transcripts in 16.5 (data not shown) and 18.5 d.p.c. fetuses (compare Figure 2b and c). Note, in particular, the high levels of MTase expression in the thymus, retina, nasal epithelium, tooth buds, vibrissae, kidney and intestine. TDG expression during postnatal development declined in most tissues including the heart, lung, liver, thymus and skin as detected by ISH (data not shown), with the exception of the testes.
TDG and MTase expression in the germline
DNA repair enzymes have essential roles in maintaining the integrity of the genome and are, therefore, often expressed in the germline. We observed differential regulation of the expression of MTase and TDG during development and maturation of the gonads. TDG was expressed at 18.5 d.p.c. in the seminiferous tubules of the fetal testis (Figure 4a ; note also the high expression levels in the mesonephros epithelium which is dierentiating into epididymis). At 10 days postpartum TDG expression remained strong in the seminiferous tubules, as well as in the epididymis epithelium ( Figure 4b ). However, expression levels decreased at puberty in seminiferous tubules of 40 and 70 day-old testes ( Figure 4c and data not shown). In contrast, strong expression persisted in the epididymis epithelium (Figure 4c ).
MTase expression evolved dierently upon testis maturation. Expression was seen in all tubules of the fetal (Figure 4a ) and prepubescent (Figure 4b ) testis. After puberty, expression remained strong, but varied among dierent seminiferous tubules of a given testis section which dier in their stage of spermatogenic cycle (Figure 4c ).
Dierential expression of TDG and MTase was also seen in the mature ovary. TDG was strongly expressed in the follicle cells of primary, Graa®an (antral) and mature follicles, but there was no labelling of the oocytes themselves (Figure 4d ). Weaker expression was seen in cells of the corpora lutea and there was no signi®cant labelling of the ovarian stroma (Figure 4d ). TDG was also strongly expressed in the epithelia of the oviduct and uterus (data not shown). MTase expression was most intense within the oocytes of primary and growing follicles, and less intense in the oocytes of mature follicles. Strong expression was detected in the follicle cells of growing follicles, and the signal became restricted to the cells surrounding the oocyte (corona radiata) in Graa®an and mature follicles (Figure 4d ). MTase expression levels varied, but were mostly low, in the corpora lutea. Some functions during tumorigenicity may be analogous to those found during development, including dedierentiation, remodelling and rapid cell proliferation. Transgenic mice expressing c-myc or v-Ha-ras under the control of the mouse mammary tumor virus (MMTV) promoter develop a hyperproliferative state of the mammary gland epithelium, followed by the appearance of tumors, upon repeated cycles of pregnancy and lactation (Sinn et al., 1987) . MMTVv-Ha-ras and MMTV-c-myc transgenic females were mated and allowed to nurse until the appearance of externally detectable mammary tumors, and these were analysed by ISH for TDG and MTase expression. Figures 5a and b respectively show TDG and MTase expression levels in the lactacting mammary epithelium of a wild-type and a MMTV-v-Ha-ras transgenic mouse that developed a mammary carcinoma. Both genes appear to be expressed at relatively low levels in the normal (wild-type) lactating mammary glandular epithelium (Figure 5a ). In contrast, they are strongly expressed in the tumor tissue of the transgenic animal, whereas expression levels are weak in the juxtaposed non-neoplastic glandular tissue and undetectable in the ®brotic stroma (Figure 5b ). TDG and MTase expression were also markedly upregulated in MMTV-c-myc transformed mammary gland tissue (Figures 5c and d ). Strong expression of both genes was seen in the tumor tissue and, to a lesser extent, in the adjacent regions of densely packed (probably hyperproliferative) epithelial cells, thus contrasting with the weak expression levels detected in the day-old mouse. The bright-®eld corresponds to the section hybridized to MTase: note the black dots in the center of the small follicles, corresponding to the accumulation of signal grains above the oocytes. Abbreviations: cl: corpus luteum; dd: ductus deferens; ep: epididymis; f: ovarian follicles at various stages of growth; gf: Graa®an follicle; mf: mature follicle; pf: primary follicle; od: oviduct; oo: oocytes; s: ovarian stroma; te: testis histologically normal mammary glandular epithelium (Figures 5c and d) .
Mice heterozygous for p53 gene disruption are at an increased risk of cancer (Donehower et al., 1992; Jacks et al., 1994) , Tumor development in these mutants requires other genetic mutations, which frequently involve inactivation of the second p53 allele (Jacks et al., 1994) . Osteosarcomas and lymphomas, along with a wide array of other tumor types, occur in these mice (Donehower et al., 1992; Jacks et al., 1994) . We have analysed TDG and MTase expression in such tumors collected from p53 heterozygous mutant mice bred in a pure 129/Sv genetic background. TDG and MTase are expressed at very low levels in the normal bone tissue of wild-type mice (Figure 6a ). Both genes were markedly upregulated in osteosarcomas from p53 mutant mice (Figure 6b ). TDG expression was stronger than that of MTase in the transformed osteoblastic cells, whereas both transcript species were undetectable in the ®brotic tissue encapsulating the tumor (Figure 6b ). Similar elevated expression of TDG and MTase was seen in a malignant lymphoma from a p53 heterozygous mouse. Note the absence of expression in the stroma (Figure 6c ).
Discussion

Coexpression of TDG and MTase may be linked to proliferation
We have found the TDG gene to be expressed in a uniform and ubiquitous manner during mouse embryonic and early fetal development, and to be upregulated in speci®c cell populations during late gestation. TDG repair activity may thus be critically required in all regions of the conceptus throughout early development. This requirement may be linked to the high proliferative activity of most embryonic areas and the need to maintain a low mutation rate between each replication step. The switch between uniform and tissue-speci®c expression of TDG occurs while most fetal organs undergo histological and functional dierentiation. The areas of strong TDG expression generally correspond to the proliferative cell compartments of various organs (e.g. the crypt cell populations of the intestinal epithelium). Interestingly, the same areas also show high levels of MTase gene activity. MTase expression is upregulated during S phase (Szyf et al., 1991) as the enzyme follows the replication machinery to methylate the newly synthesized DNA strand (Leonhardt et al., 1992) . During this phase, the enzyme is also available to remethylate hemimethylated sites left by TDG-mediated G/T mismatch repair (see Figure 7 ). Unlike MTase, no changes in the level of TDG were found during the cell cycle (MH unpublished results). Our data suggest that high expression of both TDG and MTase is required to avoid mutation ®xation through deamination of Me-C. Since the deamination rate is believed to be constant, variations in the rate of cell division may be responsible for mutation ®xation (Robertson and Jones, 1997). Proliferation-based upregulation of TDG may reduce the chance that any G/T mismatches will be repaired by the DNA replication-linked system (homologous to TDG MTase bacterial MutS). This replication-linked repair system enacts a random correction of the mispaired base, which would be wrong 50% of the time (Heby, 1995) .
TDG MTase
TDG and MTase expression in the germline
Sex-and sequence-speci®c patterns of DNA methylation are established during gametogenesis and are important for the regulation of gene expression, as well as for genomic imprinting. Quantitative studies of MTase expression during mouse testicular differentiation show a peak of expression at 6 ± 10 days postpartum and a decline by about 40% upon maturation. MTase expression in the mature testis is restricted to haploid round spermatids (Benoit and Trasler, 1994) . Here, we ®nd that both TDG and MTase expression in the seminiferous tubules is highest prior to testicular maturation. Other DNA repair enzymes are abundantly expressed in the testis (Alcivar et al., 1992; Walter et al., 1994; Koken et al., 1996) . Interestingly, targeted disruption of two genes involved in mismatch repair, MLH-2 (Wind et al., 1995) and PMS2 (Baker et al., 1995) , results in defective spermatogenesis, suggesting speci®c meiotic functions for each. Whether TDG has a speci®c meiotic function remains to be determined.
In the oocyte, high levels of expression of MTase have been documented. Interesting, oocyte MTase exists as an inactive form which is concentrated in the peripheral cytoplasm of the egg (Carlson et al., 1992) . TDG mRNA is not expressed in detectable quantities in the oocyte and therefore does not colocalize with this inactive form of MTase.
Implications of TDG and MTase expression for cancer development
The tissue-speci®c pattern of TDG expression is similar to that reported for the p53 gene at corresponding fetal stages (Schmid et al., 1991) . Regions of overlapping expression include the renal cortex, basal crypt cells of the intestine, lung, nasal epithelium, ameloblast cells of the tooth, hair follicles and thymus. p53 sequences are fully methylated at CpG sites in many tissues, which probably predisposes this gene to a high mutation rate at Me-C sites (Tornaletti and Pfeifer, 1995) . Moreover, inactivating C to T transitions in the p53 gene are frequently found in tissues such as the colon, breast, skin, lung and hematopoetic system (Tornaletti and Pfeifer, 1995) . Upregulation of TDG is expected to prevent the accumulation of such C to T mutations in cells requiring p53 function. High expression of MTase re¯ects sites of hypermethylation: DNA hypermethylation may in fact re¯ect a predisposition to cell transformation, through the intrinsic mutability of Me-C (Wu et al., 1993; Makos et al., 1993a,b; Jackson-Grusby and Jaenisch, 1996) . High MTase activity is found in many cancer cell lines, potentially providing selective growth advantages (Kautiainen and Jones, 1986) . In human colon carcinomas MTase activity directly correlates with the degree of malignancy (El-Diery et al., 1991) . Inhibition of methylation in vivo by combining 5-azacytidine-induced demethylation and heterozygous de®ciency (haploinsuciency) of the MTase gene, dramatically inhibits the development of malignant intestinal polyps in the multiple intestinal neoplasia (Min) mouse which has a mutation in the adenomatosis polyposis coli (Apc) gene (Laird et al., 1995) . It is noteworthy that 5-azacytidine is eective in repression of colon polyp development only when administered soon after birth.
We have shown that transgenic mice overexpressing the v-Ha-ras or c-myc genes in the mammary gland also speci®cally overexpress MTase and TDG at the level of the transformed tissue. Perhaps MTase activity is part of the additional events proposed to be necessary for full oncogenic transformation to occur in these mice (Sinn et al., 1987) . Oncogenic ras induces MTase activity through AP-1 sites in the MTase promoter in cells . Forced expression of a dominant negative jun reverts the transformation and results in a genome-wide reduction in DNA methylation .
We have also shown upregulation of MTase and TDG in tumors from mice lacking one functional copy of the p53 gene. It is possible that, as in fetal tissues, high TDG activity is required to prevent the accumulation of C to T mutations resulting from high DNA methylation in proliferating cells. However, since C to T mutations are the most frequent cause of mutagenesis in human disease (Cooper and Yousso®an, 1988) , it is likely that TDG fails to repair all G : T mismatches. Further studies will be required to understand why both MTase and TDG are upregulated in highly proliferative tumor cells and to what extent non-fully ecient repair of methylation-induced mutations can account for tumor development.
Materials and methods
Wild-type CD1 mice were mated overnight, and fertilization was assessed by detection of a vaginal sperm plug. The next morning was considered as 0.5 day post-coitum (d.p.c.) Young embryos (7.5 ± 9.5 d.p.c.) were collected in utero and frozen in OCT (Tissue-Tek) embedding medium. Older embryos and fetuses were dissected out of the uterus and frozen without embedding medium. Serial sections (10 mm) were made using a standard cryostat and collected on gelatincoated slides. Prior to in situ hybridization, the slides were stored at 7808C.
Mouse TDG cDNA was initially cloned in our laboratory in a yeast two-hybrid screen using retinoic acid receptor a as a bait (MH, S Um, PC, manuscript in preparation). In order to produce antisense riboprobes, a 2.3 kb TDG cDNA fragment was cloned in pBluescript SK + , linearized with HindIII and transcribed using the T7 promoter. The MTase cDNA (Bestor et al., 1988) cloned in pBluescript SK + was linearized with BamHI and transcribed using the T7 promoter. Probe synthesis and in situ hybridization procedures were as described (Niederreither and DolleÂ , 1997) .
Transgenic mice expressing c-myc or v-Ha-ras under the control of the mouse mammary tumor virus (MMTV) promoter (Sinn et al., 1987) were obtained from Charles River Laboratories. Mice heterozygous for p53 gene disruption on a 129/sv pure genetic background (Jacks et al., 1994) were obtained from the Jackson Laboratories.
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